Floatz logo

Therapeutic Asset Ratings

6,308 results matching 1 filter

91,564 assets7,904 sponsors3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
Eb-Car30-Nk
Cortical Thymoma
Beijing BiotechP1/2CC (47)
Eb-Car5-Nk
Cortical Thymoma
Beijing BiotechP1/2CC (47)
Eb-Carmsln-Nk
Cortical Thymoma
Beijing BiotechP1/2CC (47)
Ebnk-001
Breast Cancer
Essen BiotechP1/2CC (47)
Ebnk-001
Leukemia
Essen BiotechP1/2CC (47)
Ebnk-001
Liver Cancer
Essen BiotechP1/2CC (47)
Ebnk-001
Skin Carcinoma
Essen BiotechP1/2CC (47)
Eb-Select Single-Target Car-Nk Cells
Colorectal Cancer
Essen BiotechP1/2CC (47)
ect204 t cells
Liver Cancer
Eureka Therapeutics Inc.P1/2CC (47)
Eflornithine
Astrocytoma, IDH-Mutant, Grade 4
Mayo ClinicP1/2CC (47)
Eflornithine
Hormone Receptor-Positive Breast Cancer
Aminex Therapeutics, Inc.P1/2CC (47)
Eflornithine
Ovarian Cancer
Aminex Therapeutics, Inc.P1/2CC (47)
Elacestrant
Central Nervous System Disorder
Stemline Therapeutics, Inc.P1/2CC (47)
Elacestrant
Neoplasm
Stemline Therapeutics, Inc.P1/2CC (47)
Elranatamab
Hematopoietic And Lymphoid System Neoplasm
CellCentric Ltd.P1/2CC (47)
emb07
Aggressive B-Cell Non-Hodgkin Lymphoma
Shanghai EpimAb Biotherapeutics Co., Ltd.P1/2CC (47)
Enitociclib
Non-Hodgkin Lymphoma
National Cancer Institute (NCI)P1/2CC (47)
Entinostat
Vaginal Cancer
National Cancer Institute (NCI)P1/2CC (47)
Entinostat
Vulva Cancer
National Cancer Institute (NCI)P1/2CC (47)
Entrectinib
Central Nervous System Neoplasm
Hoffmann-La RocheP1/2CC (47)
ep0062
Hormone Receptor-Positive Breast Cancer
Ellipses PharmaP1/2CC (47)
Epcoritamab
Mantle Cell Lymphoma
GenmabP1/2CC (47)
Esomeprazole
Fatty Liver Disease
Sadat City UniversityP1/2CC (47)
et140203 t cells
Hepatoblastoma
Eureka Therapeutics Inc.P1/2CC (47)
Etoposide
Large Cell Neuroendocrine Carcinoma
Phanes TherapeuticsP1/2CC (47)
Showing 2326 to 2350 of 6,308 assets
PreviousPage 94 of 253Next